summary slide.png (95.03 kB)
A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of A Topical Estradiol Ophthalmic Formulation in Post-Menopausal Women With Moderate-To-Severe Dry Eye Disease
media
posted on 2021-03-09, 12:39 authored by figshare admin adisjournalsfigshare admin adisjournals, Doreen Schmidl, László Szalai, Orsolya G. Kiss, Leopold Schmetterer, Gerhard GarhöferArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
